Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Rapid phenotyping towards personalized malaria medicine.

Veiga MI, Peng WK.

Malar J. 2020 Feb 11;19(1):68. doi: 10.1186/s12936-020-3149-4.

2.

Multigenic architecture of piperaquine resistance trait in Plasmodium falciparum.

Silva M, Calçada C, Teixeira M, Veiga MI, Ferreira PE.

Lancet Infect Dis. 2020 Jan;20(1):26-27. doi: 10.1016/S1473-3099(19)30689-9. No abstract available.

PMID:
31876497
3.

Portable Device for Optical Quantification of Hemozoin in Diluted Blood Samples.

Catarino SO, Felix P, Sousa PJ, Pinto V, Veiga MI, Minas G.

IEEE Trans Biomed Eng. 2020 Feb;67(2):365-371. doi: 10.1109/TBME.2019.2913454. Epub 2019 Apr 26.

PMID:
31034403
4.

Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy.

Silva M, Ferreira PE, Otienoburu SD, Calçada C, Ngasala B, Björkman A, Mårtensson A, Gil JP, Veiga MI.

J Antimicrob Chemother. 2019 Jul 1;74(7):1890-1893. doi: 10.1093/jac/dkz098.

PMID:
30869127
5.

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa.

Inoue J, Silva M, Fofana B, Sanogo K, Mårtensson A, Sagara I, Björkman A, Veiga MI, Ferreira PE, Djimde A, Gil JP.

Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.180370. Epub 2018 Aug 17.

6.

Dosage of Single Low-Dose Primaquine to Stop Malaria Transmission.

Cruz M, Sánchez IM, Diaz J, Cuevas F, Silva M, Disla M, Ferreira PE, Veiga MI.

J Infect Dis. 2018 May 5;217(11):1849-1850. doi: 10.1093/infdis/jiy108. No abstract available.

PMID:
29529291
7.

Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.

Vanaerschot M, Lucantoni L, Li T, Combrinck JM, Ruecker A, Kumar TRS, Rubiano K, Ferreira PE, Siciliano G, Gulati S, Henrich PP, Ng CL, Murithi JM, Corey VC, Duffy S, Lieberman OJ, Veiga MI, Sinden RE, Alano P, Delves MJ, Lee Sim K, Winzeler EA, Egan TJ, Hoffman SL, Avery VM, Fidock DA.

Nat Microbiol. 2017 Oct;2(10):1403-1414. doi: 10.1038/s41564-017-0007-4. Epub 2017 Aug 14.

8.

Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.

Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnädig N, Uhlemann AC, Martin RE, Lehane AM, Fidock DA.

Nat Commun. 2016 May 18;7:11553. doi: 10.1038/ncomms11553.

9.

Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.

Veiga MI, Osório NS, Ferreira PE, Franzén O, Dahlstrom S, Lum JK, Nosten F, Gil JP.

Antimicrob Agents Chemother. 2014 Dec;58(12):7390-7. doi: 10.1128/AAC.03337-14. Epub 2014 Sep 29.

10.

Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.

Jovel IT, Ferreira PE, Veiga MI, Malmberg M, Mårtensson A, Kaneko A, Zakeri S, Murillo C, Nosten F, Björkman A, Ursing J.

Infect Genet Evol. 2014 Jun;24:111-5. doi: 10.1016/j.meegid.2014.03.004. Epub 2014 Mar 20.

PMID:
24657918
11.

pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine.

Veiga MI, Ferreira PE, Malmberg M, Jörnhagen L, Björkman A, Nosten F, Gil JP.

Antimicrob Agents Chemother. 2012 Jul;56(7):3615-9. doi: 10.1128/AAC.06350-11. Epub 2012 Apr 16.

12.

Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.

Jovel IT, Mejía RE, Banegas E, Piedade R, Alger J, Fontecha G, Ferreira PE, Veiga MI, Enamorado IG, Bjorkman A, Ursing J.

Malar J. 2011 Dec 19;10:376. doi: 10.1186/1475-2875-10-376.

13.

PfMDR1: mechanisms of transport modulation by functional polymorphisms.

Ferreira PE, Holmgren G, Veiga MI, Uhlén P, Kaneko A, Gil JP.

PLoS One. 2011;6(9):e23875. doi: 10.1371/journal.pone.0023875. Epub 2011 Sep 1.

14.

Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.

Veiga MI, Ferreira PE, Jörnhagen L, Malmberg M, Kone A, Schmidt BA, Petzold M, Björkman A, Nosten F, Gil JP.

PLoS One. 2011;6(5):e20212. doi: 10.1371/journal.pone.0020212. Epub 2011 May 25.

15.

Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.

Ghanchi NK, Ursing J, Beg MA, Veiga MI, Jafri S, Mårtensson A.

Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18.

16.

Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression.

Veiga MI, Ferreira PE, Schmidt BA, Ribacke U, Björkman A, Tichopad A, Gil JP.

PLoS One. 2010 Aug 25;5(8):e12408. doi: 10.1371/journal.pone.0012408.

17.

Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa.

Dahlström S, Ferreira PE, Veiga MI, Sedighi N, Wiklund L, Mårtensson A, Färnert A, Sisowath C, Osório L, Darban H, Andersson B, Kaneko A, Conseil G, Björkman A, Gil JP.

J Infect Dis. 2009 Nov 1;200(9):1456-64. doi: 10.1086/606009.

PMID:
19807279
18.

Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment.

Dahlström S, Veiga MI, Mårtensson A, Björkman A, Gil JP.

Antimicrob Agents Chemother. 2009 Jun;53(6):2553-6. doi: 10.1128/AAC.00091-09. Epub 2009 Apr 13.

19.

In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.

Sisowath C, Petersen I, Veiga MI, Mårtensson A, Premji Z, Björkman A, Fidock DA, Gil JP.

J Infect Dis. 2009 Mar 1;199(5):750-7. doi: 10.1086/596738.

20.

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

Veiga MI, Asimus S, Ferreira PE, Martins JP, Cavaco I, Ribeiro V, Hai TN, Petzold MG, Björkman A, Ashton M, Gil JP.

Eur J Clin Pharmacol. 2009 Apr;65(4):355-63. doi: 10.1007/s00228-008-0573-8. Epub 2008 Nov 1.

PMID:
18979093
21.

Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6).

Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP.

Infect Genet Evol. 2008 May;8(3):340-5. doi: 10.1016/j.meegid.2008.02.002. Epub 2008 Feb 15.

PMID:
18359278
22.

Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa.

Ferreira PE, Veiga MI, Cavaco I, Martins JP, Andersson B, Mushin S, Ali AS, Bhattarai A, Ribeiro V, Björkman A, Gil JP.

Ther Drug Monit. 2008 Feb;30(1):10-5. doi: 10.1097/FTD.0b013e31815e93c6.

PMID:
18223457
23.

Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.

Eriksen J, Mwankusye S, Mduma S, Veiga MI, Kitua A, Tomson G, Petzold MG, Swedberg G, Gustafsson LL, Warsame M.

Trans R Soc Trop Med Hyg. 2008 Feb;102(2):137-42. Epub 2007 Dec 21.

PMID:
18082233
24.

The Vietnamese Khin population harbors particular N-acetyltransferase 2 allele frequencies.

Cavaco I, Asimus S, Peyrard-Janvid M, Ferreira PE, Veiga MI, Hai TN, Ribeiro V, Ashton M, Gil JP.

Clin Chem. 2007 Nov;53(11):1977-9. No abstract available.

PMID:
17954500
25.

Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum.

Veiga MI, Ferreira PE, Björkman A, Gil JP.

Mol Cell Probes. 2006 Apr;20(2):100-4. Epub 2006 Feb 7.

PMID:
16460912
26.

Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y.

Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Björkman A.

Infect Genet Evol. 2006 Jul;6(4):309-14. Epub 2005 Nov 2.

PMID:
16271310

Supplemental Content

Loading ...
Support Center